This report aims to provide a comprehensive presentation of the global market for Hematopoietic Stem Cells (HSCs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematopoietic Stem Cells (HSCs). This report contains market size and forecasts of Hematopoietic Stem Cells (HSCs) in global, including the following market information:
Global Hematopoietic Stem Cells (HSCs) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Hematopoietic Stem Cells (HSCs) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Leukocyte Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hematopoietic Stem Cells (HSCs) include Kite Pharma Inc., Thermo Fisher Scientific, PromoCell, CellGenix Technologie Transfer GmbH, Cesca Therapeutics Inc., R&D Systems, Genlantis, Lonza Group Ltd. and TiGenix N.V., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hematopoietic Stem Cells (HSCs) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hematopoietic Stem Cells (HSCs) Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hematopoietic Stem Cells (HSCs) Market Segment Percentages, by Type, 2022 (%)
Leukocyte
Lymphocytes
Red Blood Cells
Platelets
Global Hematopoietic Stem Cells (HSCs) Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hematopoietic Stem Cells (HSCs) Market Segment Percentages, by Application, 2022 (%)
Blood System Diseases
Autoimmune Diseases
Other
Global Hematopoietic Stem Cells (HSCs) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hematopoietic Stem Cells (HSCs) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hematopoietic Stem Cells (HSCs) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hematopoietic Stem Cells (HSCs) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Kite Pharma Inc.
Thermo Fisher Scientific
PromoCell
CellGenix Technologie Transfer GmbH
Cesca Therapeutics Inc.
R&D Systems
Genlantis
Lonza Group Ltd.
TiGenix N.V.
ScienCell Research Laboratories
China Cord Blood Corporation
Vcanbio
Boyalife
Beike Biotechnology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hematopoietic Stem Cells (HSCs), market overview.
Chapter 2: Global Hematopoietic Stem Cells (HSCs) market size in revenue.
Chapter 3: Detailed analysis of Hematopoietic Stem Cells (HSCs) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hematopoietic Stem Cells (HSCs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hematopoietic Stem Cells (HSCs) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hematopoietic Stem Cells (HSCs) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hematopoietic Stem Cells (HSCs) Overall Market Size
2.1 Global Hematopoietic Stem Cells (HSCs) Market Size: 2022 VS 2035
2.2 Global Hematopoietic Stem Cells (HSCs) Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hematopoietic Stem Cells (HSCs) Players in Global Market
3.2 Top Global Hematopoietic Stem Cells (HSCs) Companies Ranked by Revenue
3.3 Global Hematopoietic Stem Cells (HSCs) Revenue by Companies
3.4 Top 3 and Top 5 Hematopoietic Stem Cells (HSCs) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hematopoietic Stem Cells (HSCs) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hematopoietic Stem Cells (HSCs) Players in Global Market
3.6.1 List of Global Tier 1 Hematopoietic Stem Cells (HSCs) Companies
3.6.2 List of Global Tier 2 and Tier 3 Hematopoietic Stem Cells (HSCs) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hematopoietic Stem Cells (HSCs) Market Size Markets, 2022 & 2035
4.1.2 Leukocyte
4.1.3 Lymphocytes
4.1.4 Red Blood Cells
4.1.5 Platelets
4.2 By Type - Global Hematopoietic Stem Cells (HSCs) Revenue & Forecasts
4.2.1 By Type - Global Hematopoietic Stem Cells (HSCs) Revenue, 2018-2023
4.2.2 By Type - Global Hematopoietic Stem Cells (HSCs) Revenue, 2024-2035
4.2.3 By Type - Global Hematopoietic Stem Cells (HSCs) Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hematopoietic Stem Cells (HSCs) Market Size, 2022 & 2035
5.1.2 Blood System Diseases
5.1.3 Autoimmune Diseases
5.1.4 Other
5.2 By Application - Global Hematopoietic Stem Cells (HSCs) Revenue & Forecasts
5.2.1 By Application - Global Hematopoietic Stem Cells (HSCs) Revenue, 2018-2023
5.2.2 By Application - Global Hematopoietic Stem Cells (HSCs) Revenue, 2024-2035
5.2.3 By Application - Global Hematopoietic Stem Cells (HSCs) Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Hematopoietic Stem Cells (HSCs) Market Size, 2022 & 2035
6.2 By Region - Global Hematopoietic Stem Cells (HSCs) Revenue & Forecasts
6.2.1 By Region - Global Hematopoietic Stem Cells (HSCs) Revenue, 2018-2023
6.2.2 By Region - Global Hematopoietic Stem Cells (HSCs) Revenue, 2024-2035
6.2.3 By Region - Global Hematopoietic Stem Cells (HSCs) Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Hematopoietic Stem Cells (HSCs) Revenue, 2018-2035
6.3.2 US Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.3.3 Canada Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.3.4 Mexico Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Hematopoietic Stem Cells (HSCs) Revenue, 2018-2035
6.4.2 Germany Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.4.3 France Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.4.4 U.K. Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.4.5 Italy Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.4.6 Russia Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.4.7 Nordic Countries Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.4.8 Benelux Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Hematopoietic Stem Cells (HSCs) Revenue, 2018-2035
6.5.2 China Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.5.3 Japan Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.5.4 South Korea Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.5.5 Southeast Asia Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.5.6 India Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Hematopoietic Stem Cells (HSCs) Revenue, 2018-2035
6.6.2 Brazil Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.6.3 Argentina Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue, 2018-2035
6.7.2 Turkey Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.7.3 Israel Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.7.4 Saudi Arabia Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
6.7.5 UAE Hematopoietic Stem Cells (HSCs) Market Size, 2018-2035
7 Hematopoietic Stem Cells (HSCs) Companies Profiles
7.1 Kite Pharma Inc.
7.1.1 Kite Pharma Inc. Company Summary
7.1.2 Kite Pharma Inc. Business Overview
7.1.3 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Major Product Offerings
7.1.4 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Revenue in Global Market (2018-2023)
7.1.5 Kite Pharma Inc. Key News & Latest Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Major Product Offerings
7.2.4 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Revenue in Global Market (2018-2023)
7.2.5 Thermo Fisher Scientific Key News & Latest Developments
7.3 PromoCell
7.3.1 PromoCell Company Summary
7.3.2 PromoCell Business Overview
7.3.3 PromoCell Hematopoietic Stem Cells (HSCs) Major Product Offerings
7.3.4 PromoCell Hematopoietic Stem Cells (HSCs) Revenue in Global Market (2018-2023)
7.3.5 PromoCell Key News & Latest Developments
7.4 CellGenix Technologie Transfer GmbH
7.4.1 CellGenix Technologie Transfer GmbH Company Summary
7.4.2 CellGenix Technologie Transfer GmbH Business Overview
7.4.3 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Major Product Offerings
7.4.4 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Revenue in Global Market (2018-2023)
7.4.5 CellGenix Technologie Transfer GmbH Key News & Latest Developments
7.5 Cesca Therapeutics Inc.
7.5.1 Cesca Therapeutics Inc. Company Summary
7.5.2 Cesca Therapeutics Inc. Business Overview
7.5.3 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Major Product Offerings
7.5.4 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Revenue in Global Market (2018-2023)
7.5.5 Cesca Therapeutics Inc. Key News & Latest Developments
7.6 R&D Systems
7.6.1 R&D Systems Company Summary
7.6.2 R&D Systems Business Overview
7.6.3 R&D Systems Hematopoietic Stem Cells (HSCs) Major Product Offerings
7.6.4 R&D Systems Hematopoietic Stem Cells (HSCs) Revenue in Global Market (2018-2023)
7.6.5 R&D Systems Key News & Latest Developments
7.7 Genlantis
7.7.1 Genlantis Company Summary
7.7.2 Genlantis Business Overview
7.7.3 Genlantis Hematopoietic Stem Cells (HSCs) Major Product Offerings
7.7.4 Genlantis Hematopoietic Stem Cells (HSCs) Revenue in Global Market (2018-2023)
7.7.5 Genlantis Key News & Latest Developments
7.8 Lonza Group Ltd.
7.8.1 Lonza Group Ltd. Company Summary
7.8.2 Lonza Group Ltd. Business Overview
7.8.3 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Major Product Offerings
7.8.4 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Revenue in Global Market (2018-2023)
7.8.5 Lonza Group Ltd. Key News & Latest Developments
7.9 TiGenix N.V.
7.9.1 TiGenix N.V. Company Summary
7.9.2 TiGenix N.V. Business Overview
7.9.3 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Major Product Offerings
7.9.4 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Revenue in Global Market (2018-2023)
7.9.5 TiGenix N.V. Key News & Latest Developments
7.10 ScienCell Research Laboratories
7.10.1 ScienCell Research Laboratories Company Summary
7.10.2 ScienCell Research Laboratories Business Overview
7.10.3 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Major Product Offerings
7.10.4 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Revenue in Global Market (2018-2023)
7.10.5 ScienCell Research Laboratories Key News & Latest Developments
7.11 China Cord Blood Corporation
7.11.1 China Cord Blood Corporation Company Summary
7.11.2 China Cord Blood Corporation Business Overview
7.11.3 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Major Product Offerings
7.11.4 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Revenue in Global Market (2018-2023)
7.11.5 China Cord Blood Corporation Key News & Latest Developments
7.12 Vcanbio
7.12.1 Vcanbio Company Summary
7.12.2 Vcanbio Business Overview
7.12.3 Vcanbio Hematopoietic Stem Cells (HSCs) Major Product Offerings
7.12.4 Vcanbio Hematopoietic Stem Cells (HSCs) Revenue in Global Market (2018-2023)
7.12.5 Vcanbio Key News & Latest Developments
7.13 Boyalife
7.13.1 Boyalife Company Summary
7.13.2 Boyalife Business Overview
7.13.3 Boyalife Hematopoietic Stem Cells (HSCs) Major Product Offerings
7.13.4 Boyalife Hematopoietic Stem Cells (HSCs) Revenue in Global Market (2018-2023)
7.13.5 Boyalife Key News & Latest Developments
7.14 Beike Biotechnology
7.14.1 Beike Biotechnology Company Summary
7.14.2 Beike Biotechnology Business Overview
7.14.3 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Major Product Offerings
7.14.4 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Revenue in Global Market (2018-2023)
7.14.5 Beike Biotechnology Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hematopoietic Stem Cells (HSCs) Market Opportunities & Trends in Global Market
Table 2. Hematopoietic Stem Cells (HSCs) Market Drivers in Global Market
Table 3. Hematopoietic Stem Cells (HSCs) Market Restraints in Global Market
Table 4. Key Players of Hematopoietic Stem Cells (HSCs) in Global Market
Table 5. Top Hematopoietic Stem Cells (HSCs) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hematopoietic Stem Cells (HSCs) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hematopoietic Stem Cells (HSCs) Product Type
Table 9. List of Global Tier 1 Hematopoietic Stem Cells (HSCs) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hematopoietic Stem Cells (HSCs) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Hematopoietic Stem Cells (HSCs) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hematopoietic Stem Cells (HSCs) Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Hematopoietic Stem Cells (HSCs) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hematopoietic Stem Cells (HSCs) Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2024-2035
Table 30. Kite Pharma Inc. Company Summary
Table 31. Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Product Offerings
Table 32. Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn) & (2018-2023)
Table 33. Kite Pharma Inc. Key News & Latest Developments
Table 34. Thermo Fisher Scientific Company Summary
Table 35. Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Product Offerings
Table 36. Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn) & (2018-2023)
Table 37. Thermo Fisher Scientific Key News & Latest Developments
Table 38. PromoCell Company Summary
Table 39. PromoCell Hematopoietic Stem Cells (HSCs) Product Offerings
Table 40. PromoCell Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn) & (2018-2023)
Table 41. PromoCell Key News & Latest Developments
Table 42. CellGenix Technologie Transfer GmbH Company Summary
Table 43. CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Product Offerings
Table 44. CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn) & (2018-2023)
Table 45. CellGenix Technologie Transfer GmbH Key News & Latest Developments
Table 46. Cesca Therapeutics Inc. Company Summary
Table 47. Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Product Offerings
Table 48. Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn) & (2018-2023)
Table 49. Cesca Therapeutics Inc. Key News & Latest Developments
Table 50. R&D Systems Company Summary
Table 51. R&D Systems Hematopoietic Stem Cells (HSCs) Product Offerings
Table 52. R&D Systems Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn) & (2018-2023)
Table 53. R&D Systems Key News & Latest Developments
Table 54. Genlantis Company Summary
Table 55. Genlantis Hematopoietic Stem Cells (HSCs) Product Offerings
Table 56. Genlantis Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn) & (2018-2023)
Table 57. Genlantis Key News & Latest Developments
Table 58. Lonza Group Ltd. Company Summary
Table 59. Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Product Offerings
Table 60. Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn) & (2018-2023)
Table 61. Lonza Group Ltd. Key News & Latest Developments
Table 62. TiGenix N.V. Company Summary
Table 63. TiGenix N.V. Hematopoietic Stem Cells (HSCs) Product Offerings
Table 64. TiGenix N.V. Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn) & (2018-2023)
Table 65. TiGenix N.V. Key News & Latest Developments
Table 66. ScienCell Research Laboratories Company Summary
Table 67. ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Product Offerings
Table 68. ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn) & (2018-2023)
Table 69. ScienCell Research Laboratories Key News & Latest Developments
Table 70. China Cord Blood Corporation Company Summary
Table 71. China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Product Offerings
Table 72. China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn) & (2018-2023)
Table 73. China Cord Blood Corporation Key News & Latest Developments
Table 74. Vcanbio Company Summary
Table 75. Vcanbio Hematopoietic Stem Cells (HSCs) Product Offerings
Table 76. Vcanbio Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn) & (2018-2023)
Table 77. Vcanbio Key News & Latest Developments
Table 78. Boyalife Company Summary
Table 79. Boyalife Hematopoietic Stem Cells (HSCs) Product Offerings
Table 80. Boyalife Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn) & (2018-2023)
Table 81. Boyalife Key News & Latest Developments
Table 82. Beike Biotechnology Company Summary
Table 83. Beike Biotechnology Hematopoietic Stem Cells (HSCs) Product Offerings
Table 84. Beike Biotechnology Hematopoietic Stem Cells (HSCs) Revenue (US$, Mn) & (2018-2023)
Table 85. Beike Biotechnology Key News & Latest Developments
List of Figures
Figure 1. Hematopoietic Stem Cells (HSCs) Segment by Type in 2022
Figure 2. Hematopoietic Stem Cells (HSCs) Segment by Application in 2022
Figure 3. Global Hematopoietic Stem Cells (HSCs) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hematopoietic Stem Cells (HSCs) Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Hematopoietic Stem Cells (HSCs) Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hematopoietic Stem Cells (HSCs) Revenue in 2022
Figure 8. By Type - Global Hematopoietic Stem Cells (HSCs) Revenue Market Share, 2018-2035
Figure 9. By Application - Global Hematopoietic Stem Cells (HSCs) Revenue Market Share, 2018-2035
Figure 10. By Type - Global Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Hematopoietic Stem Cells (HSCs) Revenue Market Share, 2018-2035
Figure 12. By Application - Global Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Hematopoietic Stem Cells (HSCs) Revenue Market Share, 2018-2035
Figure 14. By Region - Global Hematopoietic Stem Cells (HSCs) Revenue Market Share, 2018-2035
Figure 15. By Country - North America Hematopoietic Stem Cells (HSCs) Revenue Market Share, 2018-2035
Figure 16. US Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Hematopoietic Stem Cells (HSCs) Revenue Market Share, 2018-2035
Figure 20. Germany Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 21. France Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Hematopoietic Stem Cells (HSCs) Revenue Market Share, 2018-2035
Figure 28. China Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 32. India Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Hematopoietic Stem Cells (HSCs) Revenue Market Share, 2018-2035
Figure 34. Brazil Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Hematopoietic Stem Cells (HSCs) Revenue Market Share, 2018-2035
Figure 37. Turkey Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Hematopoietic Stem Cells (HSCs) Revenue, (US$, Mn), 2018-2035
Figure 41. Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. PromoCell Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. R&D Systems Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Genlantis Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. TiGenix N.V. Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Vcanbio Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Boyalife Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Beike Biotechnology Hematopoietic Stem Cells (HSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
